UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

Oncogene, 2013-03, Vol.32 (11), p.1341-1350

2013

Link zum Volltext

Verfügbarkeit prüfen

Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells

Oncogene, 2012-05, Vol.31 (20), p.2512-2520

2012

Link zum Volltext

Verfügbarkeit prüfen

PARPi after PARPi in epithelial ovarian cancer

Gynecologic oncology reports, 2021-02, Vol.35, p.100699, Article 100699

2021

Link zum Volltext

Verfügbarkeit prüfen

Brachytherapy Should Not be Omitted When Treating Locally Advanced Neuroendocrine Cervical Cancer with Definitive Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E290-E291

2016

Link zum Volltext

Verfügbarkeit prüfen

Minority race is a significant risk factor for treatment by non-gynecologic oncologists in women with pelvic malignancies

Gynecologic oncology, 2017-06, Vol.145, p.71-71

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of estrogen therapy on ovarian tumor cells treated with cisplatin

Gynecologic oncology, 2017-06, Vol.145, p.200-200

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of activated estrogen receptor signaling targets in ovarian cancer

Gynecologic oncology, 2014-11, Vol.135 (2), p.398-398

2014

Link zum Volltext

Verfügbarkeit prüfen

A multiinstitutional, prospective randomized open-blinded end-point trial for safety of oral apixaban versus subcutaneous enoxaparin for thromboprophylaxis in women with suspected gynecologic malignancy

Gynecologic oncology, 2017-06, Vol.145, p.221-221

2017

Link zum Volltext

Verfügbarkeit prüfen

A prospective, randomized, open-blinded endpoint (PROBE) trial for safety of oral apixaban vs subcutaneous enoxaparin for thromboprophylaxis in women with a suspected gynecologic malignancy

Gynecologic oncology, 2017-06, Vol.145, p.55-56

2017

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab-induced hypertension in gynecological cancer: Does it resolve after completion of therapy?

Gynecologic oncology, 2016-06, Vol.141, p.144-144

2016

Link zum Volltext

Verfügbarkeit prüfen

Histopathology discrepancy of preoperative endometrial sampling and final specimen: How does this influence selective lymph node dissection?

Gynecologic oncology, 2016-06, Vol.141, p.115-116

2016

Link zum Volltext

Verfügbarkeit prüfen

Awareness of symptoms and risk factors of ovarian cancer in a population of women and health care providers

Gynecologic oncology, 2014-11, Vol.135 (2), p.397-398

2014

Link zum Volltext

Verfügbarkeit prüfen

Identification of a gene expression signature to distinguish uterine leiomyosarcomas from leiomyomas

Gynecologic oncology, 2014-11, Vol.135 (2), p.397-397

2014

Link zum Volltext

Verfügbarkeit prüfen

OB/GYN residency inadequately prepares residents for fellowship training in gynecologic oncology: Results of national, multi-institutional survey

Gynecologic oncology, 2015-10, Vol.139 (1), p.181-182

2015

Link zum Volltext

Verfügbarkeit prüfen

Postoperative pulmonary complications are increased among obese patients undergoing robotic surgery for suspected gynecologic malignancy

Gynecologic oncology, 2015-10, Vol.139 (1), p.197-198

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of preoperative chemotherapy on postoperative morbidity and mortality in patients undergoing surgery for ovarian cancer

Gynecologic oncology, 2015-06, Vol.137 (3), p.598-599

2015

Link zum Volltext

Verfügbarkeit prüfen

Prolonged steep Trendelenburg positioning increases the risk of postoperative morbidity in patients undergoing robotic surgery for presumed gynecologic malignancy

Gynecologic oncology, 2015-04, Vol.137, p.54-54

2015

Link zum Volltext

Verfügbarkeit prüfen

Cytokeratin 5 positive cells represent a therapy resistant subpopulation in epithelial ovarian cancer

Gynecologic oncology, 2015-10, Vol.139 (1), p.205-206

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparative surgical outcomes in endometrial cancer patients staged with robotics or laparotomy 65 years and older

Gynecologic oncology, 2014-06, Vol.133, p.164-164

2014

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study

Gynecologic oncology, 2014-06, Vol.133, p.3-3

2014

Link zum Volltext

Verfügbarkeit prüfen

Sexual and marital dysfunction in women with gynecologic cancer: Results of a multi-institutional, cross-sectional trial

Gynecologic oncology, 2015-04, Vol.137, p.51-51

2015

Link zum Volltext

Verfügbarkeit prüfen

A cost comparison between robotic and open hysterectomy for obese women with endometrial cancer. A cost-minimization analysis

Gynecologic oncology, 2012-03, Vol.125, p.S149-S149

2012

Link zum Volltext

Verfügbarkeit prüfen

Lymphovascular space invasion and peritoneal cytology are not affected by the use of minimally invasive surgical approaches in patients with endometrial cancer

Gynecologic oncology, 2014-11, Vol.135 (2), p.403-404

2014

Link zum Volltext

Verfügbarkeit prüfen

Neuropathic pain inhibitor Kindolor augments efficacy of gemcitabine and paclitaxel in ovarian cancer cell lines, allowing reduced chemotherapy concentration

Gynecologic oncology, 2013-07, Vol.130 (1), p.e129-e129

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: A GOG study

Gynecologic oncology, 2014-06, Vol.133, p.40-40

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(93)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Obstetrics And Gynecology
(34)
Female
(33)
Hematology, Oncology And Palliative Medicine
(33)
Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Oncology
(23)
Middle Aged
(19)
Obstetrics & Gynecology
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Tumors
(15)
Aged
(13)
Gynecology. Andrology. Obstetrics
(13)
Female Genital Diseases
(12)
Adult
(11)
Aged, 80 And Over
(7)
Cancer Research
(7)
Ovarian Cancer
(7)
Ovarian Neoplasms - Genetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells

PARPi after PARPi in epithelial ovarian cancer

Brachytherapy Should Not be Omitted When Treating Locally Advanced Neuroendocrine Cervical Cancer with Definitive Chemoradiation Therapy

Minority race is a significant risk factor for treatment by non-gynecologic oncologists in women with pelvic malignancies

Effect of estrogen therapy on ovarian tumor cells treated with cisplatin

Identification of activated estrogen receptor signaling targets in ovarian cancer

A multiinstitutional, prospective randomized open-blinded end-point trial for safety of oral apixaban versus subcutaneous enoxaparin for thromboprophylaxis in women with suspected gynecologic malignancy

A prospective, randomized, open-blinded endpoint (PROBE) trial for safety of oral apixaban vs subcutaneous enoxaparin for thromboprophylaxis in women with a suspected gynecologic malignancy

Bevacizumab-induced hypertension in gynecological cancer: Does it resolve after completion of therapy?

Histopathology discrepancy of preoperative endometrial sampling and final specimen: How does this influence selective lymph node dissection?

Awareness of symptoms and risk factors of ovarian cancer in a population of women and health care providers

Identification of a gene expression signature to distinguish uterine leiomyosarcomas from leiomyomas

OB/GYN residency inadequately prepares residents for fellowship training in gynecologic oncology: Results of national, multi-institutional survey

Postoperative pulmonary complications are increased among obese patients undergoing robotic surgery for suspected gynecologic malignancy

Effect of preoperative chemotherapy on postoperative morbidity and mortality in patients undergoing surgery for ovarian cancer

Prolonged steep Trendelenburg positioning increases the risk of postoperative morbidity in patients undergoing robotic surgery for presumed gynecologic malignancy

Cytokeratin 5 positive cells represent a therapy resistant subpopulation in epithelial ovarian cancer

Comparative surgical outcomes in endometrial cancer patients staged with robotics or laparotomy 65 years and older

A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study

Sexual and marital dysfunction in women with gynecologic cancer: Results of a multi-institutional, cross-sectional trial

A cost comparison between robotic and open hysterectomy for obese women with endometrial cancer. A cost-minimization analysis

Lymphovascular space invasion and peritoneal cytology are not affected by the use of minimally invasive surgical approaches in patients with endometrial cancer

Neuropathic pain inhibitor Kindolor augments efficacy of gemcitabine and paclitaxel in ovarian cancer cell lines, allowing reduced chemotherapy concentration

A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: A GOG study

Suchergebnisse filtern